Patents by Inventor Susan D. Jones

Susan D. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized affinity matured anti-FcRn antibodies
    Patent number: 10822417
    Abstract: Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to human serum albumin. The FcRn-binding proteins can be used to treat a variety of disorders including acute and chronic toxic exposure.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: November 3, 2020
    Assignee: Syntimmune, Inc.
    Inventors: Laurence J. Blumberg, Richard S. Blumberg, Susan D. Jones, Derry Roopenian, Robert George E. Holgate, Timothy D. Jones, Arron R. Hearn
  • HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
    Publication number: 20200207854
    Abstract: Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to IgG Fc. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: February 25, 2020
    Publication date: July 2, 2020
    Inventors: Laurence J. Blumberg, Richard S. Blumberg, Susan D. Jones, Derry Roopenian, Robert George Edward Holgate, Timothy David Jones, Arron Robert Hearn
  • HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
    Publication number: 20200181262
    Abstract: Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to IgG Fc. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: February 25, 2020
    Publication date: June 11, 2020
    Inventors: Laurence J. Blumberg, Richard S. Blumberg, Susan D. Jones, Derry Roopenian, Robert George Edward Holgate, Timothy David Jones, Arron Robert Hearn
  • HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
    Publication number: 20190135915
    Abstract: Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to human serum albumin. The FcRn-binding proteins can be used to treat a variety of disorders including acute and chronic toxic exposure.
    Type: Application
    Filed: April 25, 2017
    Publication date: May 9, 2019
    Inventors: Laurence J. Blumberg, Richard S. Blumberg, Susan D. Jones, Derry Roopenian, Robert George E. Holgate, Timothy D. Jones, Arron R. Hearn
  • Epidermal growth factor protein and gene, and methods of use therefor
    Patent number: 7037504
    Abstract: Forms of epidermal growth factor that are resistant to proteolysis, and gene sequences encoding these forms and having codons optimized for usage by an industrial production organism, are provided.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: May 2, 2006
    Assignee: Waratah Pharmaceuticals, Inc.
    Inventors: Sheila G. Magil, Susan D. Jones, Gary W. Pace, Stephen J. Brand
  • Novel epidermal growth factor protein and gene, and methods of use therefor
    Publication number: 20030171269
    Abstract: Forms of epidermal growth factor that are resistant to proteolysis, and gene sequences encoding these forms and having codons optimized for usage by an industrial production organism, are provided.
    Type: Application
    Filed: October 23, 2001
    Publication date: September 11, 2003
    Inventors: Sheila G. Magil, Susan D. Jones, Gary W. Pace, Stephen J. Brand